![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
G Damsma, GS Robertson, CS Tham and HC Fibiger
Department of Psychiatry, University of British Columbia, Vancouver, Canada.
The dopaminergic regulation of striatal cholinergic activity was studied using in vivo microdialysis to measure interstitial concentrations of acetylcholine (ACh) and choline in the striata of freely moving rats. The quaternary acetylcholinesterase inhibitor neostigmine (100 nM) was included in the perfusion solution to increase the recovery of ACh. d-Amphetamine (2 mg/kg, s.c.) and nomifensine (5 mg/kg, s.c.) increased the concentration of ACh in the striatal dialysate by 40 to 60%. Interstitial choline concentrations were reduced by both drugs. Administration of the selective D1 receptor antagonist SCH 23390 (0.3 mg/kg, s.c.) decreased the concentration of ACh in the striatal dialysate by 15 to 20%; in contrast, the selective D2 antagonist raclopride (1 mg/kg, s.c.) increased striatal ACh release by 50 to 60%. Raclopride also briefly increased the extracellular concentration of choline. Raclopride blocked the increase in locomotor activity produced by d-amphetamine, but did not further enhance ACh release. In contrast, SCH 23390 completely antagonized the increases in locomotion and striatal ACh release produced by d-amphetamine. These results indicate that d-amphetamine increases ACh release in the striatum via a D1 receptor mechanism. Consistent with this hypothesis, the selective D1 receptor agonist CY 208-243 (1 mg/kg, s.c.) increased striatal ACh release by approximately 60%. In contrast, local application of CY 208-243 (10 microM) and SCH 23390 (10 microM) failed to alter ACh concentrations in the striatal dialysate. Inclusion of the noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 (10 microM) in the striatal perfusion solution significantly attenuated the increase in striatal ACh release produced by systemic CY 208- 243.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  S. S. Saklayen, O. S. Mabrouk, and E. A. Pehek Negative Feedback Regulation of Nigrostriatal Dopamine Release: Mediation by Striatal D1 Receptors J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 342 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Aosaki, K. Kiuchi, and Y. Kawaguchi Dopamine D1-Like Receptor Activation Excites Rat Striatal Large Aspiny Neurons In Vitro J. Neurosci., July 15, 1998; 18(14): 5180 - 5190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. F. Domino and L. Ni Trihexyphenidyl Interactions with the Dopamine D1-Selective Receptor Agonist SKF-82958 and the D2-Selective Receptor Agonist N-0923 in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Hemiparkinsonian Monkeys J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 307 - 311. [Abstract] [Full Text]
|
|
|
|
|
|
E. D. Abercrombie and P. DeBoer Substantia Nigra D1 Receptors and Stimulation of Striatal Cholinergic Interneurons by Dopamine: A Proposed Circuit Mechanism J. Neurosci., November 1, 1997; 17(21): 8498 - 8505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Bickerdike and E. D. Abercrombie Striatal Acetylcholine Release Correlates with Behavioral Sensitization in Rats Withdrawn from Chronic Amphetamine J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 818 - 826. [Abstract] [Full Text]
|
|
|
|
|
|
J. Q. Wang and J. F. McGinty The Full D1 Dopamine Receptor Agonist SKF-82958 Induces Neuropeptide mRNA in the Normosensitive Striatum of Rats: Regulation of D1/D2 Interactions by Muscarinic Receptors J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 972 - 982. [Abstract] [Full Text]
|
|
|
|
|
|
E. Acquas, C. Wilson, and H. C. Fibiger Nonstriatal Dopamine D1 Receptors Regulate Striatal Acetylcholine Release In Vivo J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 360 - 368. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. L. Masterman and J. L. Cummings Frontal-subcortical circuits: the anatomic basis of executive, social and motivated behaviors J Psychopharmacol, January 1, 1997; 11(2): 107 - 114. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
